These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22266865)

  • 1. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
    Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
    Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.
    Li Y; Alsagabi M; Fan D; Bova GS; Tewfik AH; Dehm SM
    Cancer Res; 2011 Mar; 71(6):2108-17. PubMed ID: 21248069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
    Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
    Dehm SM; Schmidt LJ; Heemers HV; Vessella RL; Tindall DJ
    Cancer Res; 2008 Jul; 68(13):5469-77. PubMed ID: 18593950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
    Krause WC; Shafi AA; Nakka M; Weigel NL
    Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.
    Stockley J; Markert E; Zhou Y; Robson CN; Elliott DJ; Lindberg J; Leung HY; Rajan P
    Sci Rep; 2015 Aug; 5():13426. PubMed ID: 26310125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
    Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
    Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the androgen receptor splicing in prostate cancer cells.
    Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X
    Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.
    Sun S; Sprenger CC; Vessella RL; Haugk K; Soriano K; Mostaghel EA; Page ST; Coleman IM; Nguyen HM; Sun H; Nelson PS; Plymate SR
    J Clin Invest; 2010 Aug; 120(8):2715-30. PubMed ID: 20644256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
    Chan SC; Li Y; Dehm SM
    J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.
    Hu R; Isaacs WB; Luo J
    Prostate; 2011 Nov; 71(15):1656-67. PubMed ID: 21446008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of potential regulatory signaling molecules correlate with androgen receptor splice variants AR-V7 and AR-V567es in prostate cancer metastasis.
    Kiliccioglu I; Bilen CY; Sozen S; Konac E
    Gene; 2021 Mar; 772():145377. PubMed ID: 33359129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
    Zhang X; Morrissey C; Sun S; Ketchandji M; Nelson PS; True LD; Vakar-Lopez F; Vessella RL; Plymate SR
    PLoS One; 2011; 6(11):e27970. PubMed ID: 22114732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatively spliced androgen receptor variants.
    Dehm SM; Tindall DJ
    Endocr Relat Cancer; 2011 Oct; 18(5):R183-96. PubMed ID: 21778211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequence.
    Honda M; Kimura T; Kamata Y; Tashiro K; Kimura S; Koike Y; Sato S; Yorozu T; Furusato B; Takahashi H; Kiyota H; Egawa S
    Prostate; 2019 Jun; 79(9):1043-1052. PubMed ID: 30998834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.
    Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.